ATE157870T1 - Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma - Google Patents

Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Info

Publication number
ATE157870T1
ATE157870T1 AT95100934T AT95100934T ATE157870T1 AT E157870 T1 ATE157870 T1 AT E157870T1 AT 95100934 T AT95100934 T AT 95100934T AT 95100934 T AT95100934 T AT 95100934T AT E157870 T1 ATE157870 T1 AT E157870T1
Authority
AT
Austria
Prior art keywords
optionally substituted
hydrogen
treatment
ophthalmic composition
benzoxathiepine
Prior art date
Application number
AT95100934T
Other languages
English (en)
Inventor
Takahiro Ogawa
Takaaki Deguchi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE157870T1 publication Critical patent/ATE157870T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT95100934T 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma ATE157870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP747094 1994-01-27

Publications (1)

Publication Number Publication Date
ATE157870T1 true ATE157870T1 (de) 1997-09-15

Family

ID=11666688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95100934T ATE157870T1 (de) 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Country Status (9)

Country Link
US (1) US5538974A (de)
EP (1) EP0667156B1 (de)
KR (1) KR950032169A (de)
CN (1) CN1116928A (de)
AT (1) ATE157870T1 (de)
CA (1) CA2141176A1 (de)
DE (1) DE69500660T2 (de)
ES (1) ES2106573T3 (de)
TW (1) TW316235B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) * 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
ATE310566T1 (de) 1998-09-18 2005-12-15 Alcon Mfg Ltd 5ht2-agoniste zur behandlung des glaukoms
JP2004538240A (ja) * 2000-03-31 2004-12-24 パーデュー・リサーチ・ファウンデーション ホスホラミデートおよびそのための方法
FR2822467B1 (fr) * 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
CA2469663A1 (en) * 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
PT1534391E (pt) * 2002-07-19 2007-05-31 Biovitrum Ab Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht
PL375564A1 (en) * 2002-08-30 2005-11-28 Alcon, Inc. Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
CA2506204A1 (en) * 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
WO2005018608A1 (ja) * 2003-08-20 2005-03-03 Santen Pharmaceutical Co., Ltd. 微粒子テノン嚢下投与ドラッグデリバリーシステム
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
WO2005058911A2 (en) * 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US20050276867A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
WO2006062839A1 (en) * 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EA200900583A1 (ru) * 2006-10-20 2009-08-28 Общество С Ограниченной Ответственностью "Митотехнология" Композиция для регенерации, стимуляции роста и адаптации растений к различным стрессовым факторам
EA200900582A1 (ru) * 2006-10-20 2009-08-28 Общество С Ограниченной Ответственностью "Митотехнология" Фармацевтические композиции для профилактики и лечения глазных патологий
EP2145623A4 (de) * 2007-01-29 2010-10-27 Ltd Liability Company Mitotech Pharmazeutische und kosmetische zusammensetzungen zur beschleunigten heilung von wunden und anderen oberflächenschäden
WO2008094062A1 (en) * 2007-01-29 2008-08-07 Limited Liability Company 'mitotechnology' Pharmaceutical compositions useful for preventing and treating oncological diseases
EA016723B1 (ru) * 2007-02-27 2012-07-30 Дели Инститьют Оф Фармасьютикал Сайнсиз Энд Рисерч (Дипсар) Синергетическая травяная композиция, применяемая при глаукоме, и способ ее получения
WO2008127138A1 (fr) * 2007-04-11 2008-10-23 Limited Liability Company 'mitotechnology' Composition visant à ralentir le vieillissement et à allonger la durée de vie de l'organisme et utilisation de cette composition
WO2009005386A1 (en) 2007-06-29 2009-01-08 Limited Liability Company 'mitotechnology' Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
WO2010056145A1 (ru) 2008-11-12 2010-05-20 Общество С Ограниченной Ответственностью "Митотехнология" Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов
AU2009347921B8 (en) 2009-06-10 2014-07-24 Mitotech Sa Pharmaceutical composition for use in medical and veterinary ophthalmology
BR112012011197A2 (pt) 2009-11-13 2020-10-20 Obschestvo S Ogranichennoi Otvetsvennostyu "Mitotekh" subtâncias farmacêuticas com base em antioxidantes direcionados à mitocôndria
CA2820425A1 (en) 2010-12-20 2012-06-28 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
EP2714024B1 (de) 2011-06-03 2018-10-03 Mitotech SA Orale formulierungen aus auf mitochondrien gerichteten antioxidantien sowie herstellung und verwendung davon
CN112439071B (zh) * 2019-09-04 2022-05-20 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
EP0229467A1 (de) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin-Derivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
TW316235B (de) 1997-09-21
ES2106573T3 (es) 1997-11-01
US5538974A (en) 1996-07-23
EP0667156B1 (de) 1997-09-10
CN1116928A (zh) 1996-02-21
DE69500660D1 (de) 1997-10-16
EP0667156A1 (de) 1995-08-16
DE69500660T2 (de) 1998-02-26
KR950032169A (ko) 1995-12-20
CA2141176A1 (en) 1995-07-28

Similar Documents

Publication Publication Date Title
ATE157870T1 (de) Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
IL98382A0 (en) Heterocyclene derivatives
ATE112762T1 (de) Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
ATE161723T1 (de) Arzneimittel zur verwendung bei der behandlung von parkinsonismus
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE69008542D1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
DE69611502D1 (de) (Oxo-1-Alkyl)amino-2-desoxy-2-glucopyranosid von Dihydroxy-2,3-propyl, Verfahren zur Herstellung und ihre Verwendungen
DE69706355D1 (de) Alkylendiamin-Derivate als Arzneimittel zur Behandlung von Geschwüren und Hemmung von Helicobacter pylori
EP0635011A1 (de) Hydrazid-derivate von 3,4-dihydro-2h-1-benzopyranen.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE122892T1 (de) Zusammensetzung gegen katarakt.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE120461T1 (de) Imidazolylpropylguanidinderivat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties